Open AccessImpact of Unlabeled French Antibiotic Guidelines On Antibiotic Prescriptions For Acute Respiratory Tract Infections In 7 Pediatric Emergency Departments, 2009–2012
Author(s) -
François Angoulvant,
Marcy Lancia Pereira,
Francis Perreaux,
V. Soussan,
Luu-Ly Pham,
Thanh-Van Trieu,
B. Cojocaru,
Romain Guedj,
Robert Cohen,
Corinne Alberti,
Vincent Gajdos
Publication year - 2014
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000000125
Subject(s) - amoxicillin , medicine , medical prescription , antibiotics , respiratory tract infections , cefpodoxime , throat , clavulanic acid , emergency department , respiratory tract , intensive care medicine , emergency medicine , respiratory system , antibacterial agent , surgery , pharmacology , microbiology and biotechnology , psychiatry , biology
From November 2009 to October 2012, implementation of guidelines, unlabeled by the French Agency of Health Products, changed the categories of antibiotics prescribed for acute respiratory tract infections in 7 pediatric emergency departments. During the study, 36,413 acute respiratory tract infections-related antibiotic prescriptions were prescribed. Amoxicillin prescriptions rose from 30.0% to 84.7%, while amoxicillin-clavulanate and cefpodoxime prescriptions decreased to 10.2% and 2.5%, respectively.